Analysed AVAI BIO INC (AVAI:OTCMKTS) News Sources
Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference
07-04-2026
yahoo.com
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
03-03-2026
yahoo.com
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website
11-02-2026
yahoo.com
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
26-01-2026
yahoo.com
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
16-12-2025
yahoo.com
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
09-12-2025
yahoo.com
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
18-11-2025
yahoo.com
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
04-11-2025
yahoo.com
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
21-10-2025
yahoo.com
What is the current price of AVAI BIO INC (AVAI:OTCMKTS)?
The current price of AVAI BIO INC (AVAI:OTCMKTS) is $0.3241.
AVAI BIO INC (AVAI:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AVAI BIO INC (AVAI:OTCMKTS) since the previous trading day is $0.0041.
AVAI BIO INC (AVAI:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AVAI BIO INC (AVAI:OTCMKTS) since the previous trading day is 1.2812%.
What is the most recent average sentiment score for AVAI BIO INC (AVAI:OTCMKTS)?
The most recent average sentiment score for AVAI BIO INC (AVAI:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for AVAI BIO INC (AVAI:OTCMKTS)?
The most recent sentiment for AVAI BIO INC (AVAI:OTCMKTS) is .
SEC-8K** Filing Available For AVAI BIO INC (AVAI:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.